Abstract
We aimed to evaluate the long-term natural history of polypoidal choroidal vasculopathy (PCV) in untreated patients. This is a retrospective observational case series. Patients with symptomatic PCV who did not receive any treatment for at least 12months were included from the records of three ophthalmic clinics in Asia. The medical records and imaging data were reviewed. Visual outcomes at month 12 and at last follow-up were analyzed. The influence of demographics and presenting features on visual outcome was analyzed. A total of 32 eyes (32 patients) were included in this analysis. The mean follow-up was 59.9months (range, 18-119months), the mean age was 65.7years and 21 (65.6%) patients were male. The mean presenting logMAR visual acuity was 0.79 (Standard deviation [SD] 0.49). The center of the fovea was involved by the PCV complex in 25 eyes (78.1%). The mean greatest linear dimension (GLD) of the PCV complex was 2584μm (SD 880). Twenty-three eyes (71.9%) had a cluster-of-grapes configuration on indocyanine green angiography. Leakage of fluorescein angiography was present in 29 eyes (90.6%). The mean logMAR vision deteriorated from 0.79 at baseline to 0.88 at month 12 (p = 0.11), and further to 1.14 (p = 0.003) at the last follow-up. The proportion of eyes that improved, remained unchanged and worsened was 21.9%, 31.3% and 46.9%, respectively, at month 12; and 28.1%, 9.4% and 62.5%, respectively, at last follow-up. The proportion of eyes with logMAR vision worse than 1.0 was 28.1% at presentation, and increased to 31.3% at month 12 and further to 53.1% at last follow-up. Reasons for poor vision were due to retinal, subretinal or vitreous hemorrhage, and retinal pigment epithelium (RPE) atrophy and scarring. None of the presenting features were found to significantly influence visual outcome. Half of eyes presenting with symptomatic PCV had a relatively benign course without treatment and some even had vision improvement. However, in the remaining eyes, vision deteriorated significantly, mainly due to hemorrhage and scarring. There may be subtypes of PCV with divergent natural history.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Graefe's Archive for Clinical and Experimental Ophthalmology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.